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Carbohydrate microarrays provide access to high through-put analysis of protein–carbohydrate
interactions. Herein we demonstrate the use of SPR imaging (SPRi) of glycoarrays to assess the ligand
specificity of the reputedly galactose-specific plant lectin RCA120 (Ricinus communis agglutinin 120),
a surrogate for the bioterrorism agent ricin. Glycoarray studies identified RCA120 ligands based on
galactose substituted at the 6-position with sialic acid. These observations, which were confirmed by
saturation transfer difference (STD) NMR spectroscopy studies, inspired the synthesis of non-natural
6-substituted galactose derivatives, which were shown to have 3–4 fold enhanced binding to RCA120
with respect to the unsubstituted compound. These novel unnatural galactosides, which are chemically
and biologically more robust than their natural glycan counterparts, represent new potential ligands for
the development of carbohydrate-based ricin sensors.
Introduction
Major advances in analytical glycoscience over the past decade
or so present many new opportunities for identifying carbohy-
drate–ligand interactions of biological significance.1–4 In partic-
ular, the development of carbohydrate and lectin microarrays5–9
provides access to quantitative, high throughput screening
approaches that could not previously have been contemplated.
In addition to the identification of natural ligands, these tech-
nologies also provide a basis for the rapid optimisation of non-
natural ligands for carbohydrate-binding proteins, as exemplified
by work on novel sialic acid derivatives,10 some of which serve as
high affinity ligands for sialic acid-binding lectins (Siglecs).11 In
the course of work on the development of ricin sensors,12 we had
cause to consider the identification of novel ligands, and hence
turned to carbohydrate microarrays.13
Ricin is a lethal, ribosome-inactivating protein14,15 found in
plants that are used for castor oil production. Its lectin-like B-
chain facilitates adhesion of the toxin to non-reducing terminal
galactose residues of glycoproteins on mammalian cell surfaces,
resulting in the delivery of the toxic A-chain warhead into the
cytosol. The A-chain catalyses the hydrolytic cleavage of a single
base from eukaryotic ribosomal RNA, leading to a shutdown in
protein synthesis and ultimately cell death. Ricin is several
thousand times more toxic to man than cyanide, with the lethal
dose for an adult estimated to be around 500 ng Kg1 of body
weight.14,15 Due to its high toxicity and accessibility, its potential
as a biowarfare agent has long been recognised, with several
recent incidents in the UK and the US resulting in threats to
public safety.14,15 While recent efforts have identified potential
leads for the development of anti-ricin inhibitors,16 a rapid
method for the early detection of traces of the toxin remains an
important goal.{ Given the carbohydrate-binding properties of
ricin B-chain, carbohydrate-based sensors are potentially
attractive. Certain systems have been shown to exhibit very high
selectivity for bacterial toxins17 and plant lectins, including
ricin;12,18,19 related carbohydrate-based sensing platforms have
also been used for bacterial detection.20–25 In addition, galactose-
coated gold nanoparticles in a colorimetric assay12 for the
detection of Ricinus communis agglutinin (RCA120), a surrogate
for ricin (RCA60),
26 afforded higher sensitivity than antibody-
conjugated nanoparticles in piezoelectric immunosensing.27
Despite these early developments, D-galactosides are prevalent
in nature and many other mammalian, plant and microbial lec-
tins and enzymes recognise and/or metabolise this common
monosaccharide.28 Selectivity is therefore a primary issue. In the
context of robust ricin sensor development, we were drawn to
explore carbohydrate microarrays in the search for alternative
naturally occurring ligands for ricin that might provide insight
for the design of non-natural ligands that in turn could show
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improved selectivity. We noted that surface plasmon resonance
approaches had already been used successfully in conjunction
with D-galactoside surfaces to develop biosensors for ricin.18,19
With a view to exploring a much wider range of potential toxin
ligands, we were drawn to explore surface plasmon resonance
imaging (SPRi), an array-based approach that is finding wide use
in bimolecular interaction analysis and for the development of
affinity-based biosensors.29 We have recently employed SPRi for
the analysis of protein interactions with carbohydrate micro-
arrays.13 Here we report the further use of this technique to
analyse the interaction of RCA120 with an array of natural
glycans, which in turn informed studies on ligand (re)design to
provide unnatural sugar-based ligands for potential use in ricin
sensors.
Results and discussion
Analysis of RCA120 interaction with a carbohydrate microarray
by SPR imaging
Array generation through split-pin, contact printing of a library
of 40 biotinylated glycansk (Table 1) onto commercial neu-
travidin-coated gold sensor chips was carried out as reported
previously.13 To briefly summarise, the library assessed was
composed of a range of glycans with non-reducing termini based
on: Gal-b-1,4 (7 compounds), Gal-b-1,3 (3), GalNAc (1),
GlcNAc (4), sulfo-Gal (3), NeuAc-2,3 (12), NeuGc-2,3/2,6 (2/1),
NeuAc-2,6 (4), and NeuAc-2,8 (3) (Table 1). The array was used
to screen for RCA120 binders in the anticipation that glycans
possessing a non-reducing terminal b-linked galactose residue
(black and orange), the previously determined simple ligand for
this lectin, would stand out as hits.13,18,19 Data for equilibrium
binding of RCA120 and the a-2,6-NeuAc-specific Sambucus nigra
agglutinin (SNA) to the glycoarray are presented in Fig. 1.**
It was immediately evident from these array data that RCA120
had a preference for binding to non-reducing b-D-galactose
(strongest responses are black and orange bars). However, such
recognition was context-dependent, with Galb1-4GlcNAc (B81)
giving a stronger response than Galb1-4Glc (B80), for instance;
an extended glycan chain (e.g. B115) also gave a stronger
response than the shorter counterpart (B81). Some galactose-
terminated structures were relatively poorly recognised, in
particular branched glycans, such as Lex trisaccharide (B266) and
Lea trisaccharide (B156). As expected, RCA120 did not bind
significantly to sugars with non-reducing terminalGlcNAc (pink)
but results with sialic acid (NeuAc)-containing ligands were
intriguing (red, green, blue, purple bars). On the whole, glycans
terminated in a2-3Neu5Ac/Gc (red bars, plus B89, B90) were
poor ligands whilst those terminated in a2-6Neu5Ac/Gc (blue
bars, plus B93) showed relatively good binding to RCA120.
Extending the a2-3Neu5Ac arm with an additional a2-8Neu5Ac
residue did not recover binding (purple bars). These data are
consistent with the ability of RCA120 to accommodate substi-
tution at the 6-position of the non-reducing terminal b-galactose
with sialic acid (Fig. 2); likewise, terminal galactose 6-sulfate was
recognised by RCA120 whereas galactose 3-sulfate was not (cyan
bars, B185 and B197, respectively). Together these data
comprehensively map novel functional ‘hotspots’ for RCA120
carbohydrate binding.
Analysis of SNA interaction with a carbohydrate microarray by
SPR imaging
Given these unexpected interactions of RCA120 with a-2,6-
NeuAc-containing glycans, the glycoarray was probed with
another previously characterised a-2,6-NeuAc-specific lectin, in
this case Sambucus nigra agglutinin (SNA) (Fig. 1B). For SNA,
the only glycan ligands that were identified in this study were
three of the four a-2,6-NeuAc compounds (B87, B179, B274) and
the single a-2,6-NeuGc (B93) out of the library of forty glycans.
Together, these data confirmed the functional performance of
the array bearing this key ligand type.
Development of novel carbohydrate-based ligands for RCA120
The novel glycoarray data above revealed 6-modified D-galac-
tosides as good RCA120 ligands. To explore the potential of these
observations in the creation of bespoke ricin ligands a series of
Galb1,4-GlcNAc derivatives modified at the galactose 6-position
were designed. The intention here was to attempt to move away
from the potentially biologically and chemically labile a-2,6-
linked NeuAc compounds in favour of a more robust ligand,
which would be necessary for sensor applications. A library of
Galb1,4-GlcNAc derivatives modified at the galactose 6-position
(1–7) was devised (Scheme 1), with a view to post-synthesis
biotinylation through hydrazone chemistry32,33 (giving 1Bt–7Bt)
to enable SPRi array analysis, as above.
Syntheses of target derivatives employed the coupling
of appropriately tailored glycosyl trichloroacetimidate donors
(8–12) with a common partially protected GlcNAc acceptor (13).
Known trichloroacetimidates34 were prepared from five vari-
ously modified galactose derivatives: D-galactose (8, 97% yield),
6-deoxy-6-fluoro-D-galactose (9),35 D-fucose (10)36 (6-deoxy-D-
galactose), arabinose (11)37 (deshydroxymethyl-D-galactose) and
6-deoxy-6-azido-D-galactose (12).36 To access acceptor 13,
glycosylation of a per-O-acetyl-b-GlcNAc with benzyl alcohol
and ytterbium triflate,38,39 followed by deprotection under
Zemplen conditions, gave the corresponding benzyl glycoside. A
tert-butyldimethylsilyl protecting group was then introduced
selectively on the primary hydroxyl to give the suitably protected
glycosyl acceptor 13.40 Regioselective glycosylation41 of 13 cat-
alysed by BF3 etherate gave b-1,4-linked disaccharides 14–18
containing the desired 6-modified galactose in 27–53% yield
(Scheme 1).
Deprotection of compounds 14–17 by removal of the 6-O-silyl
group, followed by de-O-acetylation under Zemplen conditions
and removal of the anomeric benzyl protecting group by
hydrogenolysis afforded target compounds 1–4. Azidodi-
saccharide 18 served as a vital divergent intermediate for amides
5–7. Staudinger reduction42 followed by per-O-acetylation and
deprotection steps led to acetamide 5 from compound 18, whilst
compounds 6 and 7 were accessed by Staudinger reduction and
formation of amides under Schotten–Baumann conditions.43 In
order to facilitate immobilisation of this disaccharide library on
a neutravidin-coated SPR imaging chip, compounds 1–7 were
chemically derivatised at their reducing ends with 6-biotinamido
hexanoic acid hydrazide, giving biotinylated glycosyl hydra-
zides32,33 (1Bt–7Bt, Scheme 1) that were suitable for printing.
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SPR imaging analysis of RCA120 binding to a 6-substituted
galactoside library
In order to assess RCA120 recognition of unnatural galactoside
derivatives, this modified library (1Bt–7Bt) was printed directly
onto an SPR imaging chip, as described earlier. Equilibrium
binding data are reported as a bar chart for glycans printed at
100 mg mL1 concentration (ca. 150 mM) in Fig. 3.††
As was immediately apparent from Fig. 3, replacement of the
6-hydroxyl group of galactose by fluorine (2Bt), or its removal
altogether (3Bt), had limited impact on RCA120 binding
(compared to 1Bt). In contrast, removal of the 5-hydroxymethyl
group, to create 4Bt, essentially abolished binding. A significant
increase (3–4 fold) in SPR responses was generated by the pres-
ence of the designed amides [60-NHAc-(5Bt), 60-NHBz-(6Bt) and
60-NH.CO.C6H11-Galb1-4GlcNAc (7Bt)), when compared to
LacNAc (1Bt). These results are consistent with those from our
initial screen of forty natural glycans, where 60-sialyl LacNAc
terminated glycans (notably Neu5Ac/Gc-a2-6Galb1-4GlcNAc
types; red) showed significant increased affinities. However, these
unnatural ligands represent a dramatic further increase and are
the most potent known ligands thus far developed, to the best of
our knowledge.
STD NMR spectroscopy analysis of RCA120 binding to
6-modified galactosides
The data presented above clearly demonstrate that both terminal
galactose and 6-modified galactose can act as motifs in ligands
Table 1 Library of biotinylated glycans used in this study
Group name Glycotope structure Common name
B301 Galb1-4GlcNAcb1-3Galb1-3GlcNAc L-NLec
B266 Galb1-4[Fuca1-3]GlcNAc Lex
B186 Galb1-4(6OSO3)Glc 6SuLac
B115 Galb1-4GlcNAcb1-3Galb1-4Glc LNnT
B111 (Galb1-4GlcNAcb)2 Di-LN
B81 Galb1-4GlcNAc LN
B80 Galb1-4Glc Lac
B82 Galb1-3GlcNAc Lec
B156 Galb1-3[Fuca1-4]GlcNAc Lea
B277 Galb1-3GlcNAcb1-3Galb1-4GlcNAc Lec-LN
B180 GalNAcb1-4GlcNAc LDN
B299 GlcNAcb1-3Galb1-3GlcNAc GN-Lec
B181 GlcNAcb1-3Galb1-4GlcNAc GN-LN
B121 GlcNAc GN
B114 GlcNAcb1-3Galb1-4Glc LNT2
B197 [3OSO3]Galb1-4Glc 30SuLac
B187 [3OSO3]Galb1-4(6OSO3)Glc 6,30-di-SuLac
B185 (6OSO3)Galb1-4Glc 60SuLac
B298 Neu5Aca2-3[Neu5Aca2-3Galb1-3GalNAcb1-4]Galb1-4Glc GD4
B273 Neu5Aca2-3GalNAcb1-4GlcNAc 30SLDN
B204 Neu5Aca2-3[Galb1-3GalNAcb1-4]Galb1-4GlcNAc GM2(NAc)
B202 Neu5Aca2-3[Galb1-3GlcNAcb1-4]Galb1-4Glc GM1
B194 Neu5Aca2-3[Galb1-4GlcNAcb1-3]3 3
0SLN-LN-LN
B178 Neu5Aca2-3[Galb1-4GlcNAcb]2 3
0-SLN-LN
B177 Neu5Aca2-3[GalNAcb1-4]Galb1-4Glc GM2
B174 Neu5Aca2-3Galb1-3[Fuca1-4]GlcNAc SLea
B157 Neu5Aca2-3Galb1-4[Fuca1-3]GlcNAc SLex
B85 Neu5Aca2-3Galb1-3GlcNAc 30SLec
B84 Neu5Aca2-3Galb1-4GlcNAc 30SLN
B83 Neu5Aca2-3Galb1-4Glc 30SLac
B93 Neu5Gca2-6Galb1-4GlcNAc 60S(Gc)LN
B90 Neu5Gca2-3Galb1-4GlcNAc 30S(Gc)LN
B89 Neu5Gca2-3Galb1-4Glc 30S(Gc)Lac
B274 Neu5Aca2-6GalNAcb1-4GlcNAc 60SLDN
B179 Neu5Aca2-6[Galb1-4GlcNAcb]2 6
0-SLN-LN
B87 Neu5Aca2-6Galb1-4GlcNAc 60SLN
B86 Neu5Aca2-6Galb1-4Glc 60SLac
B184 Neu5Aca2-8Neu5Aca2-3[GalNAcb1-4]Galb1-4Glc GD2
B108 Neu5Aca2-8Neu5Aca2-8Neu5Aca2-3Galb1-4Glc GT3
B107 Neu5Aca2-8Neu5Aca2-3Galb1-4Glc GD3
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for RCA120. What these SPRi glycoarray data are unable to
confirm is whether both classes of ligand bind at the same site on
the lectin. We addressed this critical point through a solution
assay based on STD NMR spectroscopy.44 STD NMR relies on
saturation transfer from the lectin to the bound fraction of ligand
upon lectin irradiation at a selected resonance, followed by spin
diffusion.45,46 This approach is finding increasing use in the
analysis of carbohydrate–protein interactions.47,48 Upon addi-
tion of Galb1-4Glc (1 mM) and the 60-modified equivalent
Neu5Aca2-6Galb1-4Glc (1 mM) as ligands in excess to indi-
vidual solutions of RCA120 (30 mM), the STDNMR spectra were
recorded. Fig. 4A and 4B show the overlay of the 1D NMR
reference spectra (in blue) and the corresponding STD NMR
spectra (in red).
For Galb1-4Glc (Fig. 4A), the saturation was transferred
mainly onto H20-, H30- and H40-Gal (100, 78 and 72%) and to
a lesser extent to the other protons (H10-Gal 37% [not shown in
Fig], H50-Gal 41% and H6a,b0-Gal 39 and 46%), consistent with
literature data for methyl galactopyranoside.43 This suggested
that H20-, H30- and H40-Gal were in close contact with the
RCA120 carbohydrate binding site. In the case of the 6
0-modified
equivalent Neu5Aca2-6Galb1-4Glc (Fig. 4B), H20- and H30-Gal
Fig. 1 SPR imaging responses for equilibrium binding of (A) RCA120 (800 nM) and (B) SNA (80 nM) to an array of 40 biotinylated natural glycans
(Table 1). Data errors were typically in the 10–15% range.13
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maintained the highest levels of saturation (100 and 72%,
respectively), suggesting that these positions were integral to
ligand recognition. Agreement with this observation can be
found in lack of binding to RCA120 of a2,3Neu5Ac-terminating
oligosaccharides (red bars, Fig. 1) - i.e. substitution of the 3-
position of galactose precludes binding to RCA120, consistent
with the 3 position of galactose being situated in close proximity
to the protein on binding to RCA120. Significant differences were
observed for saturation transfer for H40-Gal signals in Galb1-
4Glc (72%) and Neu5Aca2-6Galb1-4Glc (51%) and, to a lesser
extent, for H50-Gal (41% in Galb1-4Glc; 51% in Neu5Aca2-
6Galb1-4Glc), reflecting changes in the network of interactions
Fig. 2 Structures of representative oligosaccharides identified from SPRi array analysis that (A) serve as ligands for RCA120 or (B) do not bind RCA120.
Colour coding refers to Table 1/Fig. 1.
Scheme 1 Reagents and conditions: a) BF3$OEt2, DCM, 40 C; b) 1. BF3$OEt2, CH3CN. 2. MeONa, MeOH. 3. H2, Pd(OH)2/C, MeOH for target
compounds 1–4; b) 1. PPh3, H2O; 2. Ac2O, Py; 3. BF3$OEt2; 4. MeONa, MeOH; 5. H2, Pd(OH)2/C, MeOH for target compound 5; b) 1. BF3$OEt2; 2.
MeONa, MeOH; 3. PPh3, H2O; 4. RCOCl, aq. NaHCO3; 5. H2, Pd(OH)2/C, MeOH for target compounds 6–7; c) 0.5 mol eq 6-biotinamido hexanoic
acid hydrazide, MeOH/H2O/AcOH 92 : 6 : 2, 40
C, 24 h.
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which stabilises the ligand into the binding sites, particularly
around the 4 and 5 positions of galactose. The protons from the
added 60-NeuAc group (H40 0 to H900) were also subject to some
saturation transfer (38–55%, Fig. 4B), suggesting proximity to
the protein surface in the RCA120 complex.
Importantly, competition experiments using STD NMR with
RCA120 in the presence of both Galb1-4Glc and Neu5Aca2-
6Galb1-4Glc in various ratios (SI, Figs. S18–S21†) provided
strong support for these two ligands adopting very similar
binding modes and hence competing for the same binding site on
RCA120.
Binding of 6-modified galactosides to RCA120 in other interaction
studies
Despite the widespread notion that RCA120 is specific for non-
reducing terminal b-linked D-galactose, numerous literature
reports, employing a variety of techniques, give inconsistent
evidence for the recognition of substituted galactosides. Early
studies on glycan recognition reported that, a2-3Neu5Ac and a2-
6Neu5Ac are ‘‘acceptable substituents on the terminal b-galac-
tosyl moiety’’ for binding to ricin and its surrogate RCA120.
49
However, while more recent observations by Gildersleeve and
co-authors,50 using a fluorescence glycoarray approach, identi-
fied Neu5Aca2-6Gal structures as RCA120 binders (binding
potency around 5 fold lower than lactose), a2-3Neu5Ac-con-
taining glycans were not recognised in this assay. Data from
frontal affinity chromatography studies using pyridylaminated
(PA) oligosaccharides51 show that binding affinities of LacNAc-
PA (KD 4.1 mM) and 6
0-sialyl LacNAc-PA (KD 5.6 mM) to
RCA120 were comparable. Conversely, studies carried out using
ELISA reported very low, if any, binding of sialylated lactosides
to RCA120.
52 Fluorescence glycan array data from the Consor-
tium for Functional Glycomics53 using polyacrylamide-based
glycoconjugates54 show high RCA120 binding to non-reducing
terminal Gal, Galb1-4Glc and Galb1-4GlcNAc. Interestingly,
some but not all oligosaccharides terminating in the Neu5Aca2-
6Galb1-4GlcNAc sequence were also strongly recognised on
these arrays (see SI, Fig. S17†), but glycans terminating in a2,3-
Neu5Ac or a2,8-diNeu5Ac were not recognised. The SPRi data
reported in the present study are in agreement with the Gilder-
sleeve data, demonstrating binding to a2,6-Neu5Ac-Gal but not
to a2,3-Neu5Ac-Gal (blue and red in Fig. 1, respectively). Can
these conclusions be rationalised on a structural basis?
Fig. 3 SPR imaging responses for equilibrium binding of RCA120
(800 nM) to an array of biotinylated Galb1, 4-GlcNAc derivatives
modified at the galactose 6-position (1Bt–7Bt). Data errors were typically
in the 10–15% range.13
Fig. 4 The interaction of (A) Galb1-4Glc (Lac, 1 mM) and (B) Neu5Aca2-6Galb1-4Glc (60SL, 1 mM) with RCA120 (30 mM) by STD-NMR. The
reference 1DNMR spectra (blue) are overlaid with the corresponding STDNMR spectra (red). The extent of saturation is expressed as relative intensity
of the signals, normalised to the highest intensity signal (H20-Gal for both (A) and (B)), to determine the binding epitopes. Gal residue protons are
labelled as Hx
0, whilst Neu5Ac protons are labelled as Hx0 0. The chemical structures report the extent (%) of saturation for convenience.
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Structural analysis of the binding of ricin and RCA120 with
oligosaccharide ligands
The X-ray crystal structure of RCA120 bound to b-D-gal-
actopyranose55 reveals that each molecule of the agglutinin
incorporates one carbohydrate binding site capable of forming
four hydrogen bonds with the b-Gal ligand: between Lys40 and
OH-2, Asn46 and OH-3, Gly25 and OH-1, Asp22 and OH-4
(Fig. 5a). A hydrogen bonding network is further stabilised by
hydrophobic interactions between Trp37 and the hydrophobic
lower face of b-Gal (Fig. 5b). Overall, the crystallographic data
clearly illustrate that the galactose 6-OH group does not make
key polar contacts with the protein and suggest that substitution
at this position may be accommodated; these observations are
critically consistent with the data that we have determined in the
present study.
This conclusion is further supported by low-energy conformer
distribution analyses and nOe NMR studies56,57 on ricin and
RCA120 using a series of deoxy-sugar derivatives of methyl b-
lactoside. These studies have also highlighted the importance of
positions 2, 3 and 4 in D-galactoside ligands as key polar groups
for the interaction. Furthermore, STD NMR studies44 show
saturation transfer from RCA120 to H-2, H-3 and H-4 (87, 100
and 87%, respectively) of methyl b-galactoside, but not to H-6,
which is consistent with scope to accommodate modification of
the galactose 6-OH group. Again, consideration of structural
data supports the notion that alteration and substitution of the 6-
position of galactose can be tolerated by RCA120.
Conclusions
The need for fast and sensitive detection methods for the
unequivocal identification of ricin led us to explore SPR imaging
of glycoarrays for screening ligands of the ricin surrogate
RCA120. SPRi analysis of RCA120 interaction with a 40
compound glycoarray highlighted the potential of 6-modified D-
galactosides to serve as ligand for this lectin; these observations
were further substantiated by STD NMR spectroscopy. Non-
natural 6-modified galactosides inspired by these observations
were designed, synthesised and subsequently shown to exhibit up
to a 3–4 fold enhanced RCA120 binding compared to the parent
galactoside. To our knowledge, these are the most potent non-
natural small molecule ligands currently known for RCA120. In
summary, this study demonstrates the utility of glycoarrays and
SPRi for both identifying and optimising carbohydrate ligands
(Fig. 6) in the context of devising novel ligands for ricin sensor
applications.
Experimental
Carbohydrate microarrays were prepared using biotinylated
glycans, methods and hardware essentially as reported previ-
ously.12 Along with details of the synthesis, characterisation of
the modified N-acetyllactosamines, protocols for the bio-
tinylation of these reducing sugars and STD NMR competition
experiments, this information can be found in the Electronic
Supporting Information. All STD NMR experiments were per-
formed on a Bruker Avance II 600 MHz spectrometer equipped
with a TCI cryoprobe; spectra were processed on Bruker Topspin
2.1 software. A Bruker pulsed sequence for STD-NMR (Bruker
pulse sequence code: stddiffesgp.3) was used with a shaped pulse
train for saturation alternating between on and off resonance
and a spoil pulse to destroy unwanted magnetization. The
sequence includes solvent suppression using excitation sculpting
with gradients and spinlock to suppress protein signals. On
resonance was set at 360 Hz, whilst off resonance was set
at 50,000 Hz. The number of scans varied with sample (typi-
cally 256). NMR samples were prepared in 500 mL of 99.9% D2O
buffer containing 10 mM phosphate buffer, 150 mMNaCl at pH
7.4 (not corrected for D2O). Solute exchange was achieved by
ultrafiltration of the RCA120 sample with Amicon Ultra
(Millipore) centrifugal filters (membrane cut-off 30 kDa).
Addition of the saccharides Galb1-4Glc and Neu5Aca2-6Galb1-
4Glc (Carbosynth Limited) to the protein NMR sample was
from concentrated stock solutions in 99.9% buffered D2O. The
ratio of protein to oligosaccharide was typically ca. 1 : 33. In
competition experiments, the competing carbohydrate ligand
was in 4-fold excess with respect to the primary carbohydrate
ligand and therefore in a 1 : 132 ratio with the protein. As far as
carbohydrate epitope mapping analysis was concerned, the STD
integrals of the individual protons of the two disaccharides
(Galb1,4Glc and Neu5Aca2,6Galb1,4Glc) were referenced to the
strongest STD signal in each spectrum (H20-Gal in both the
saccharides), which was assigned a value of 100%.
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